Optimizing Nutrition in Infants at High Risk for Developing Allergy
A Food Allergy CE/CME Curriculum Course

This webcast is scheduled for Wednesday, July 10th at 3pm (ET), 2pm (CT), 1pm (MT), 12pm (PT).

Tatyana Hofmekler, MD, MSc, discusses the role of human milk in preventing allergy development, as well as identifying formula options that support the needs of infants with food allergies or those at high risk for food allergies. Topics covered include an overview of nutritional and growth considerations for children; benefits of human milk and breastfeeding; identification of infants at high risk for developing allergies; the nutritional composition of infant formula options; and comparison of non-cow’s milk–based formulas and their indications for use.

This activity is part of the Food Allergy Curriculum: Understanding Food Allergies in Infants and Children: The Symptoms, Diagnoses, and Management

If you are unable to stream the webcast, you may participate via telephone by calling 888-599-8688 and entering passcode 450354 when prompted.

• Profile

  Tatyana Hofmekler, MD, MSc

  ×

  Tatyana (Tanya) Hofmekler, MD, MSc, is a pediatric gastroenterologist at GI Care for Kids/Children’s Center for Digestive Health Care in Atlanta, Georgia, the largest practice specializing in gastrointestinal care for children in the southeastern United States. She is board certified in pediatrics, pediatric gastroenterology, hepatology and nutrition, and has a special interest in inflammatory bowel disease (IBD) and intestinal rehabilitation.

  Dr. Hofmekler received her medical degree from Morehouse School of Medicine in Atlanta. She completed an internship and residency in pediatrics at Emory University, also in Atlanta, where she was awarded a fellowship in gastroenterology, hepatology and nutrition. Dr. Hofmekler’s postgraduate research, published in Genome Medicine, involved the study of the microbiome in pretreated, newly diagnosed, pediatric IBD patients.  Her additional research undertaken at Emory University, studying the effect of dosing regimen on infliximab levels in pediatric patients with IBS, was published in the Journal of Pediatric Gastroenterology and Nutrition. 

  After completion of her fellowship training, Dr. Hofmekler joined the faculty at Emory University and was appointed director of Intestinal Rehab of Children’s Healthcare of Atlanta, helping to lead quality initiatives for the group. Her academic responsibilities included the supervision and instruction of pediatric residents and medical students. Her clinical responsibilities included managing a group of over 30 patients with outpatient total parenteral nutrition in a multidisciplinary setting.

  During her tenure at Emory University, Dr. Hofmekler completed a master of science degree in clinical research, studying risk factors for hospital admission among pediatric patients with intestinal failure. She also helped to coordinate Interdisciplinary Nutrition Support Rounds between nutritionists and physicians at Egleston Children’s Hospital in Atlanta.

  Dr. Hofmekler has given numerous lectures and poster presentations and published several peer-reviewed articles. She is a member of a number of professional organizations including the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, and the Crohn’s and Colitis Foundation of America. She serves as nutrition co-chair of the Georgia Chapter of the American Academy of Pediatrics.

  Close
  

  Tatyana Hofmekler, MD, MSc

  Pediatric Gastroenterologist
  GI Care for Kids
  Atlanta, Georgia